INNOVATIVE RESEARCH & EDUCATION
The Institute for Biomedical Sciences is training future generations of leading biomedical scientists and professionals through a unique approach to education that highlights the connection among science, business and law and teaches sought-after, technical skills in our advanced labs. Our world-class researchers are tackling some of the most urgent human diseases such as COVID-19, developing new vaccines, diagnostics and therapeutics in research centers focused on microbial pathogenesis, translational immunology and inflammation, immunity and infection.
We've launched a new bachelor's degree program. The program prepares students for employment in the biomedical industry or advanced degrees in science, business or law. Learn More
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute for Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the institute each year, and the university is planning even more expansion.
More
Top Stories
Biomedical Sciences Researcher Gets $2.94 Million Federal Grant To Study Unique Features of Ebola and Marburg Viruses
Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.read more ❯
Biomedical Sciences Researchers Discover First-In-Class Broad-Inhibitor of Paramyxovirus Polymerases
A new antiviral drug that is effective against a broad range of human pathogens in the paramyxovirus family, such as the human parainfluenzaviruses and measles virus, has been discovered by researchers in the Institute for Biomedical Sciences at Georgia State University.read more ❯
Biomedical Sciences Researcher Receives $3.65 Million Federal Grant to Develop Antiviral Drugs
Dr. Richard Plemper, Distinguished University Professor in the Institute for Biomedical Sciences, has been awarded a five-year, $3.65 million grant from the National Institutes of Health to develop antiviral therapeutics for the treatment of respiratory syncytial virus (RSV) infections. read more ❯